Key result
Polycystic ovary syndrome was associated with significantly higher TRAIL protein expression in follicular granulosa cells compared to healthy controls (0.44 vs 0.33, p=0.001).
Why the study?
The relationship between ovarian and systemic immune cell homeostasis and autophagy levels in PCOS patients during pregnancy is not well understood.
Case-Control (n=158)
No
Absolute Event Rate: 0.44% vs 0.33%
p-value: p=0.001
Protein expression of follicular granule cells is significantly elevated in pregnant patients with PCOS compared to controls, highlighting potential links between cell homeostasis, autophagy, and PCOS pathology.
Immune-autophagy links in pregnant PCOS patients remain unproven; hypothesis-generating and should not yet change practice.
Polycystic Ovary Syndrome (PCOS) is a very common disease in gynecological endocrine clinics. Its clinical manifestations are heterogeneous, which seriously affects the quality of life of women. Therefore, this article proposes a study on the relationship between ovarian and systemic immune cell homeostasis and autophagy levels in patients with polycystic ovary syndrome during pregnancy, aiming to explore the relationship between cell homeostasis and autophagy in PCOS patients, and help patients get rid of them as soon as possible disease. This article mainly adopts various methods such as literature data method and experimental analysis method to gain an in-depth understanding of the clinical manifestations, pathological characteristics and related treatment research of PCOS, as well as auxiliary diagnosis methods under intelligent medical treatment. On the basis of the above theories, design Experiments related to the imbalance of cell homeostasis and autophagy level in PCOS patients. Through the serum test and glucose tolerance test of the patients, and the use of homeostasis model for evaluation, the biochemical characteristics, insulin resistance index, protein expression level and other related factors of the patients were analyzed. The protein expression of follicular granule cells in the PCOS group was higher than that in the control group (P<0.05), which was statistically different.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a case-control in Polycystic Ovary Syndrome (PCOS) (n=158). Polycystic Ovary Syndrome (PCOS) vs. Healthy controls was evaluated on TRAIL protein expression in follicular granulosa cells (p=0.001). Polycystic ovary syndrome was associated with significantly higher TRAIL protein expression in follicular granulosa cells compared to healthy controls (0.44 vs 0.33, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: